<?xml version="1.0" encoding="UTF-8"?>
<ref id="B172-viruses-12-00110">
 <label>172.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Michaelis</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Paulus</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Loschmann</surname>
    <given-names>N.</given-names>
   </name>
   <name>
    <surname>Dauth</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Stange</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Doerr</surname>
    <given-names>H.W.</given-names>
   </name>
   <name>
    <surname>Nevels</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Cinatl</surname>
    <given-names>J.</given-names>
    <suffix>Jr.</suffix>
   </name>
  </person-group>
  <article-title>The multi-targeted kinase inhibitor sorafenib inhibits human cytomegalovirus replication</article-title>
  <source>Cell. Mol. Life Sci.</source>
  <year>2011</year>
  <volume>68</volume>
  <fpage>1079</fpage>
  <lpage>1090</lpage>
  <pub-id pub-id-type="doi">10.1007/s00018-010-0510-8</pub-id>
  <pub-id pub-id-type="pmid">20803231</pub-id>
 </element-citation>
</ref>
